Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

ClinicalTrials.gov ID: NCT00611026

Public ClinicalTrials.gov record NCT00611026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder

Study identification

NCT ID
NCT00611026
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
2,417 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Feb 2, 2011

2008 – 2009

United States locations

U.S. sites
102
U.S. states
34
U.S. cities
88
Facility City State ZIP Site status
Pfizer Investigational Site Enterprise Alabama 36330 —
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Montgomery Alabama 36117 —
Pfizer Investigational Site Chandler Arizona 85225 —
Pfizer Investigational Site Peoria Arizona 85381 —
Pfizer Investigational Site Tucson Arizona 85741 —
Pfizer Investigational Site Little Rock Arkansas 72205 —
Pfizer Investigational Site Anaheim California 92801 —
Pfizer Investigational Site Clovis California 93611 —
Pfizer Investigational Site Fresno California 93710 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site Torrance California 90505 —
Pfizer Investigational Site Upland California 91786 —
Pfizer Investigational Site Vista California 92083 —
Pfizer Investigational Site Westlake Village California 91361 —
Pfizer Investigational Site Englewood Colorado 80112 —
Pfizer Investigational Site New London Connecticut 06320 —
Pfizer Investigational Site Bonita Spring Florida 34134 —
Pfizer Investigational Site Hollywood Florida 33021 —
Pfizer Investigational Site Jacksonville Florida 32205 —
Pfizer Investigational Site Jacksonville Florida 32216 —
Pfizer Investigational Site Lake Worth Florida 33461 —
Pfizer Investigational Site Leesburg Florida 34748 —
Pfizer Investigational Site Longwood Florida 32779 —
Pfizer Investigational Site Loxahatchee Groves Florida 33470 —
Pfizer Investigational Site Miami Florida 33143 —
Pfizer Investigational Site Miami Florida 33186 —
Pfizer Investigational Site Naples Florida 34102 —
Pfizer Investigational Site Pembroke Pines Florida 33024 —
Pfizer Investigational Site Stuart Florida 34996 —
Pfizer Investigational Site Tallahassee Florida 32308 —
Pfizer Investigational Site West Palm Beach Florida 33409 —
Pfizer Investigational Site Atlanta Georgia 30308 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Meridian Idaho 83642 —
Pfizer Investigational Site Chicago Illinois 60654 —
Pfizer Investigational Site Peoria Illinois 61614 —
Pfizer Investigational Site Avon Indiana 46123 —
Pfizer Investigational Site Evansville Indiana 47714 —
Pfizer Investigational Site Noblesville Indiana 46158 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Overland Park Kansas 66215 —
Pfizer Investigational Site Lexington Kentucky 40504 —
Pfizer Investigational Site Lexington Kentucky 40509 —
Pfizer Investigational Site Louisville Kentucky 40207 —
Pfizer Investigational Site Louisville Kentucky 40291 —
Pfizer Investigational Site Metairie Louisiana 70002 —
Pfizer Investigational Site Baltimore Maryland 21211 —
Pfizer Investigational Site Bel Air Maryland 21014 —
Pfizer Investigational Site North Dartmouth Massachusetts 02747 —
Pfizer Investigational Site Ann Arbor Michigan 48103 —
Pfizer Investigational Site Royal Oak Michigan 48073 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Sartell Minnesota 56377 —
Pfizer Investigational Site Olive Branch Mississippi 38654 —
Pfizer Investigational Site Picayune Mississippi 39466 —
Pfizer Investigational Site Kansas City Missouri 64114 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site Lincoln Nebraska 68506 —
Pfizer Investigational Site Lincoln Nebraska 68510 —
Pfizer Investigational Site Omaha Nebraska 68134 —
Pfizer Investigational Site Las Vegas Nevada 89148 —
Pfizer Investigational Site Hamilton New Jersey 08690 —
Pfizer Investigational Site Williamsville New York 14221 —
Pfizer Investigational Site Cary North Carolina 27518 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Raleigh North Carolina 27612 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Cincinnati Ohio 45212 —
Pfizer Investigational Site Cincinnati Ohio 45249 —
Pfizer Investigational Site Bensalem Pennsylvania 19020 —
Pfizer Investigational Site Philadelphia Pennsylvania 19114 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15243 —
Pfizer Investigational Site Uniontown Pennsylvania 15401 —
Pfizer Investigational Site Cumberland Rhode Island 02864 —
Pfizer Investigational Site Pawtucket Rhode Island 02860 —
Pfizer Investigational Site Anderson South Carolina 29621 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Summerville South Carolina 29485 —
Pfizer Investigational Site Johnson City Tennessee 37601 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site New Tazewell Tennessee 37825 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Beaumont Texas 77706 —
Pfizer Investigational Site Bryan Texas 77802 —
Pfizer Investigational Site Plano Texas 75024 —
Pfizer Investigational Site Plano Texas 75093 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Sugar Land Texas 77479 —
Pfizer Investigational Site Midvale Utah 84047 —
Pfizer Investigational Site West Jordan Utah 84088 —
Pfizer Investigational Site Arlington Virginia 22205 —
Pfizer Investigational Site Charlottesville Virginia 22911 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Virginia Beach Virginia 23455 —
Pfizer Investigational Site Virginia Beach Virginia 23464 —
Pfizer Investigational Site Weber City Virginia 24290 —
Pfizer Investigational Site Seattle Washington 98104 —
Pfizer Investigational Site Seattle Washington 98166 —
Pfizer Investigational Site Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00611026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2011 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00611026 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →